Objective:To investigate the clinical features of R-CHOP regimen in the treatment of non-Hodgkin^lymphoma with Pneumocystis carinii pneumonia(PCP)in order to improve the understanding of PCP and the side effects of Ri...Objective:To investigate the clinical features of R-CHOP regimen in the treatment of non-Hodgkin^lymphoma with Pneumocystis carinii pneumonia(PCP)in order to improve the understanding of PCP and the side effects of Rituxan.Methods:A retrospective analysis of 90 patients with non-Hodgkin’s lymphoma treated with R-CHOP chemotherapy in our hospital from November 2015 to November 2020,of which 15(16.7%)patients,combined with PCP clinical data,including clinical symptoms,physical signs,chest imaging examination and treatment data were used for to analysis and summarization.Results:The clinical features of R-CHOP chemotherapy combined with PCP were fever,cough,and sputum.Some patients had fewer clinical symptoms.Common imaging manifestations were double lung membrane glass shadow,patchy shadow,and flocculent shadow.It can occur in all clinical stages,and the incidence of late stage is high,and there is no clear correlation with bone marrow suppression.Pneumocystis was found in 2 cases of sputum,and the rest of the patients were clinically diagnosed.The main therapeutic drugs are sulfamethoxazole(8/15),compound sulfamethoxazole(6/15),clindamycin(1/15,sulfa drug allergy),and adrenal cortex hormones(4/15).Fourteen cases were cured and 1 case died.Conclusion:The incidence of R-CHOP in advanced non-Hodgkin^lymphoma of PCP is high.Patients with clinical use of R-CHOP chemotherapy will encounter fever,cough,chest computed tomography(CT)film glass shadow,and diffuse patch shadow.Patients should be alert to the possibility of PCP and take sulfonamides as soon as possible for medical treatment.展开更多
Direct dehydrogenation with high selectivity and oxidative dehydrogenation with low thermal limit has been regarded as promising methods to solve the increasing demands of light olefins and styrene.Metalbased catalyst...Direct dehydrogenation with high selectivity and oxidative dehydrogenation with low thermal limit has been regarded as promising methods to solve the increasing demands of light olefins and styrene.Metalbased catalysts have shown remarkable performance for these reactions,such as Pt,CrOx,Co,ZrOx,Zn and V.Compared with metal-based catalysts,carbon materials with stable structure,rich pore texture and large surface area,are ideal platforms as the catalysts and the supports for dehydrogenation reactions.In this review,carbon materials applied in direct dehydrogenation and oxidative dehydrogenation reactions including ordered mesoporous carbon,carbon nanodiamond,carbon nanotubes,graphene and activated carbon,are summarized.A general introduction to the dehydrogenation mechanism and active sites of carbon catalysts is briefly presented to provide a deep understanding of the carbon-based materials used in dehydrogenation reactions.The unique structure of each carbon material is presented,and the diversified synthesis methods of carbon catalysts are clarified.The approaches for promoting the catalytic activity of carbon catalysts are elaborated with respect to preparation method optimization,suitable structure design and heteroatom doping.The regeneration mechanism of carbon-based catalysts is discussed for providing guidance on catalytic performance enhancement.In addition,carbon materials as the support of metal-based catalysts contribute to exploiting the excellent catalytic performance of catalysts due to superior structural characteristics.In the end,the challenges in current research and strategies for future improvements are proposed.展开更多
文摘Objective:To investigate the clinical features of R-CHOP regimen in the treatment of non-Hodgkin^lymphoma with Pneumocystis carinii pneumonia(PCP)in order to improve the understanding of PCP and the side effects of Rituxan.Methods:A retrospective analysis of 90 patients with non-Hodgkin’s lymphoma treated with R-CHOP chemotherapy in our hospital from November 2015 to November 2020,of which 15(16.7%)patients,combined with PCP clinical data,including clinical symptoms,physical signs,chest imaging examination and treatment data were used for to analysis and summarization.Results:The clinical features of R-CHOP chemotherapy combined with PCP were fever,cough,and sputum.Some patients had fewer clinical symptoms.Common imaging manifestations were double lung membrane glass shadow,patchy shadow,and flocculent shadow.It can occur in all clinical stages,and the incidence of late stage is high,and there is no clear correlation with bone marrow suppression.Pneumocystis was found in 2 cases of sputum,and the rest of the patients were clinically diagnosed.The main therapeutic drugs are sulfamethoxazole(8/15),compound sulfamethoxazole(6/15),clindamycin(1/15,sulfa drug allergy),and adrenal cortex hormones(4/15).Fourteen cases were cured and 1 case died.Conclusion:The incidence of R-CHOP in advanced non-Hodgkin^lymphoma of PCP is high.Patients with clinical use of R-CHOP chemotherapy will encounter fever,cough,chest computed tomography(CT)film glass shadow,and diffuse patch shadow.Patients should be alert to the possibility of PCP and take sulfonamides as soon as possible for medical treatment.
基金the National Natural Science Foundation of China(Grant Nos.22179065,22111530112).
文摘Direct dehydrogenation with high selectivity and oxidative dehydrogenation with low thermal limit has been regarded as promising methods to solve the increasing demands of light olefins and styrene.Metalbased catalysts have shown remarkable performance for these reactions,such as Pt,CrOx,Co,ZrOx,Zn and V.Compared with metal-based catalysts,carbon materials with stable structure,rich pore texture and large surface area,are ideal platforms as the catalysts and the supports for dehydrogenation reactions.In this review,carbon materials applied in direct dehydrogenation and oxidative dehydrogenation reactions including ordered mesoporous carbon,carbon nanodiamond,carbon nanotubes,graphene and activated carbon,are summarized.A general introduction to the dehydrogenation mechanism and active sites of carbon catalysts is briefly presented to provide a deep understanding of the carbon-based materials used in dehydrogenation reactions.The unique structure of each carbon material is presented,and the diversified synthesis methods of carbon catalysts are clarified.The approaches for promoting the catalytic activity of carbon catalysts are elaborated with respect to preparation method optimization,suitable structure design and heteroatom doping.The regeneration mechanism of carbon-based catalysts is discussed for providing guidance on catalytic performance enhancement.In addition,carbon materials as the support of metal-based catalysts contribute to exploiting the excellent catalytic performance of catalysts due to superior structural characteristics.In the end,the challenges in current research and strategies for future improvements are proposed.
